Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Masumi Otaki"'
Autor:
Hiu Ting Chan, Satoshi Nagayama, Masumi Otaki, Yoon Ming Chin, Yosuke Fukunaga, Masashi Ueno, Yusuke Nakamura, Siew-Kee Low
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
IntroductionCirculating tumor DNA (ctDNA) has been increasingly recognized as a promising minimally-invasive biomarker that could identify patients with minimal residual disease and a high risk of recurrence after definitive treatment. In this study,
Externí odkaz:
https://doaj.org/article/147e9c2fdf894d1b8b75861d5a3c8aa5
Autor:
Hiu Ting Chan, Satoshi Nagayama, Yoon Ming Chin, Masumi Otaki, Rie Hayashi, Kazuma Kiyotani, Yosuke Fukunaga, Masashi Ueno, Yusuke Nakamura, Siew‐Kee Low
Publikováno v:
Molecular Oncology, Vol 14, Iss 8, Pp 1719-1730 (2020)
As the use of next‐generation sequencing (NGS) for plasma cell‐free DNA (cfDNA) continues to expand in clinical settings, accurate identification of circulating tumor DNA mutations is important to validate its use in the clinical management for c
Externí odkaz:
https://doaj.org/article/c7ba8e1582eb4f97ae1453d272fe05a8
Autor:
Yosuke Fukunaga, Masumi Otaki, Kazuma Kiyotani, Siew-Kee Low, Yusuke Nakamura, Masashi Ueno, Hiu Ting Chan, Rie Hayashi, Satoshi Nagayama, Yoon Ming Chin
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 14, Iss 8, Pp 1719-1730 (2020)
Molecular Oncology, Vol 14, Iss 8, Pp 1719-1730 (2020)
As the use of next‐generation sequencing (NGS) for plasma cell‐free DNA (cfDNA) continues to expand in clinical settings, accurate identification of circulating tumor DNA mutations is important to validate its use in the clinical management for c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1f848849fa9680b37f8d4747cf7b475
http://europepmc.org/articles/PMC7400786
http://europepmc.org/articles/PMC7400786
Autor:
Yoon Ming Chin, Tomoko Shibayama, Hiu Ting Chan, Masumi Otaki, Fumikata Hara, Takayuki Kobayashi, Kokoro Kobayashi, Mari Hosonaga, Ippei Fukada, Lina Inagaki, Makiko Ono, Yoshinori Ito, Shunji Takahashi, Shinji Ohno, Takayuki Ueno, Yusuke Nakamura, Siew‐Kee Low
Publikováno v:
Cancer science. 113(5)
Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) significantly improve progression-free survival and have become the standard therapy for estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e88803f08d5302a944a8b3d009051a5
https://pubmed.ncbi.nlm.nih.gov/35201661
https://pubmed.ncbi.nlm.nih.gov/35201661
Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer
Autor:
Yoshio Miki, Tomoko Shibayama, Siew-Kee Low, Yoon Ming Chin, Yoko Takahashi, Yusuke Nakamura, Hiu Ting Chan, Makoto Fujishima, Masumi Otaki, Takayuki Ueno
Publikováno v:
Cancer Science
We present a study to evaluate the feasibility and clinical utility of amplicon‐based Oncomine Pan‐Cancer cell‐free assay to detect circulating tumor DNA (ctDNA) in patients with early or advanced breast cancer. In this study, 109 early and met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f58e1ea135c71f3c7349507c74a4a9
https://pubmed.ncbi.nlm.nih.gov/33075187
https://pubmed.ncbi.nlm.nih.gov/33075187
Autor:
Takayuki Ueno, Siew-Kee Low, Yoshinori Ito, Masumi Otaki, Shunji Takahashi, Hiu Ting Chan, Shinji Ohno, Yusuke Nakamura, Tomoko Shibayama, Makiko Ono, Yoon Ming Chin
Publikováno v:
Clinical Cancer Research. 26:A29-A29
Background: CDK4/6 inhibitors are effective treatment modalities against hormone receptor-positive metastatic breast cancer (MBC). However, monitoring of clinical responses relies solely on conventional tumor markers that are insufficiently sensitive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dae16bbb6c2863afd0ad47396f59acb
https://doi.org/10.1158/1557-3265.liqbiop20-a29
https://doi.org/10.1158/1557-3265.liqbiop20-a29
Autor:
Yosuke Fukunaga, Masumi Otaki, Yusuke Nakamura, Kazuma Kiyotani, Siew-Kee Low, Hiu Ting Chan, Rie Hayashi, Masashi Ueno, Yoon Ming Chin, Satoshi Nagayama
Publikováno v:
Clinical Cancer Research. 26:A46-A46
Background: Although the prognosis of colorectal cancer (CRC) has improved in the past decade, a subset of CRC patients may still suffer from relapse due to the progression from minimal residual disease (MRD) after surgical resection. A sensitive and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee08bff6b8e79ca9715d1be5ed725918
https://doi.org/10.1158/1557-3265.liqbiop20-a46
https://doi.org/10.1158/1557-3265.liqbiop20-a46
Autor:
Makiko Ono, Yoon Ming Chin, Yoshinori Ito, Takayuki Ueno, Tomoko Shibayama, Yusuke Nakamura, Masumi Otaki, Shunji Takahashi, Shinji Ohno, Hiu Ting Chan, Siew-Kee Low
Publikováno v:
Journal of Clinical Oncology. 38:e15544-e15544
e15544 Background: CDK4/6 inhibition substantially improves progression-free survival for women with advanced estrogen receptor-positive breast cancer. Despite this, most patients experience acquired resistance. The analyses of cancer specific genomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e55475e6689bea76932ef0907deb875d
https://doi.org/10.1200/jco.2020.38.15_suppl.e15544
https://doi.org/10.1200/jco.2020.38.15_suppl.e15544
Autor:
Masumi Otaki, Satoshi Nagayama, Yoon Ming Chin, Rie Hayashi, Siew-Kee Low, Yosuke Fukunaga, Kazuma Kiyotani, Masashi Ueno, Hiu Ting Chan, Yusuke Nakamura
Publikováno v:
Journal of Clinical Oncology. 38:e15531-e15531
e15531 Background: Although the prognosis of colorectal cancer (CRC) has improved in the past decade, a subset of CRC patients may still suffer from relapse due to the progression from minimal residual disease (MRD) after surgical resection. A sensit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cf3c291e67c485ea029c3895035eeb7
https://doi.org/10.1200/jco.2020.38.15_suppl.e15531
https://doi.org/10.1200/jco.2020.38.15_suppl.e15531